Last Posted: Nov 13, 2020
- Vaccinomics and Adversomics in the Era of Precision Medicine: A Review Based on HBV, MMR, HPV, and COVID-19 Vaccines.
Omersel Jasna et al. Journal of clinical medicine 2020 Nov 9(11)
- Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines.
Scepanovic Petar, et al. Genome medicine 2018 0 (1) 59
- An Inactivated Virus Candidate Vaccine to Prevent COVID-19
MJ Mulligan, JAMA, August 13, 2020
- Genetic Variants in the IL-4/IL-13 Pathway Influence Measles Vaccine Responses and Vaccine Failure in Children from Mozambique.
Clifford Holly D, et al. Viral immunology 2017 0 (7) 472-478
- Maternal Vaccines: Part of a Healthy Pregnancy
- Measles: Make Sure Your Child is Fully Immunized
- Vaccines: Life savers against infectious diseases
Wellcome Trust Sanger Blog, August 2, 2019
- Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections.
Tian Chao, et al. Nature communications 2017 0 (1) 599
- Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.
Voigt Emily A, et al. The Journal of infectious diseases 2017 12
- Common variants associated with general and MMR vaccine-related febrile seizures.
Feenstra Bjarke, et al. Nature genetics 2014 12 (12) 1274-82
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.